Engineering an Extended Activity FGF-1
Travis Riedel, PhD, MBA — Published: January 30, 2013 Compared to wild-type, engineered recombinant human FGF-1 variant displays improved overall thermostability, a two-fold increase in resistance to trypsin proteolysis, and a drastic improvement in cell culture half-life (~40 hours, compared to 1 hour for wild-type FGF-1). This unique Extended Activity FGF-1 variant is now available exclusively from